Purdue Pharma Says Settlement Talks in Opioid Cases Not Over
In this Friday, Aug. 17, 2018, file photo, Christine Gagnon of Southington, Conn., protests with other family and friends who have lost loved ones to OxyContin and opioid overdoses at Purdue Pharma LLP headquarters in Stamford, Conn. Gagnon lost her son Michael 13 months earlier. OxyContin maker Purdue Pharma is expected to file for bankruptcy after settlement talks over the nation’s deadly overdose crisis hit an impasse, attorneys general involved in the talks said Saturday, Sept. 7, 2019, in a message to their counterparts across the country. (AP Photo/Jessica Hill, File)   OxyContin maker Purdue Pharma and la...
Source: JEMS: Journal of Emergency Medical Services News - September 9, 2019 Category: Emergency Medicine Tags: News Patient Care AP News Tag Source Type: news

Health Highlights: Sept. 9, 2019
Here are some of the latest health and medical news developments, compiled by the editors of HealthDay: Opioid Maker Purdue Pharma Expected to File for Bankruptcy Settlement talks with OxyContin maker Purdue Pharma over its role in the United... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - September 9, 2019 Category: General Medicine Source Type: news

Email: Opioid talks fail, Purdue bankruptcy filing expected
A breakdown in settlement talks with the maker of OxyContin puts the first federal trial over the opioid epidemic on track to begin next month (Source: ABC News: Health)
Source: ABC News: Health - September 8, 2019 Category: Consumer Health News Tags: Health Source Type: news

DOJ Takes Down'Pill Mill' Network for Millions of RXs DOJ Takes Down'Pill Mill' Network for Millions of RXs
In less than 15 months, one Houston-area doctor allegedly prescribed about 2 million pills of controlled substances, including over 800,000 oxycodone pills and almost 450,000 hydrocodone pills.Medscape Medical News (Source: Medscape Business of Medicine Headlines)
Source: Medscape Business of Medicine Headlines - September 4, 2019 Category: Pharmaceuticals Tags: Psychiatry News Source Type: news

Judge: Drugmakers, others can face trial over opioids crisis
A federal judge overseeing litigation related to the nation's opioids epidemic has ruled that claims against Purdue Pharma and other drug companies can move to trial as the OxyContin maker tries to reach a settlement (Source: ABC News: Health)
Source: ABC News: Health - September 3, 2019 Category: Consumer Health News Tags: Health Source Type: news

Sacklers vs. States: Settlement Talks Stumble Over Foreign Business
The Sackler family is willing to give up Purdue Pharma to settle all claims related to the opioid crisis, but is resisting a quick sale of its overseas drug company. (Source: NYT Health)
Source: NYT Health - August 31, 2019 Category: Consumer Health News Authors: Matthew Goldstein, Danny Hakim and Jan Hoffman Tags: States (US) Suits and Litigation (Civil) Pain-Relieving Drugs Opioids and Opiates Attorneys General Local Government Bankruptcies Drugs (Pharmaceuticals) OxyContin (Drug) Purdue Pharma Sackler Family your-feed-healthcare Source Type: news

Some states, towns skeptical over proposed opioid settlement
Some state attorneys general and local governments are skeptical of a proposed settlement with OxyContin maker Purdue Pharma over its role in the nation's opioid addiction crisis (Source: ABC News: Health)
Source: ABC News: Health - August 31, 2019 Category: Consumer Health News Tags: Health Source Type: news

Oregon official: Family shifted billions from opioid company
Oregon's attorney general says in a lawsuit the Sackler family siphoned $11 billion from Purdue Pharma L.P., the Oxycontin maker the family owns and which is facing numerous lawsuits, in an attempt to evade "catastrophic liability." (Source: ABC News: Health)
Source: ABC News: Health - August 31, 2019 Category: Consumer Health News Tags: Health Source Type: news

Opioid settlement would use a formula to split the money
The multibillion-dollar settlement that the maker of OxyContin is negotiating to settle a crush of lawsuits over the nation's opioid crisis contains formulas for dividing up the money among state and local governments across the country, The Associated Press has learned. (Source: CBC | Health)
Source: CBC | Health - August 30, 2019 Category: Consumer Health News Tags: News/Business Source Type: news

AP Source: OxyContin Maker Seeks to Resolve All Lawsuits
This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)   COLUMBUS, Ohio (AP) — A settlement being pursued by the maker of OxyContin aims to resolve all claims against the company filed in both state and federal courts and provides a formula for dividing a pot of ...
Source: JEMS: Journal of Emergency Medical Services News - August 29, 2019 Category: Emergency Medicine Tags: News AP News Tag Source Type: news

OxyContin maker negotiating settlement worth a reported $12B
Published reports say Purdue Pharma and the thousands of state and local governments suing the maker of OxyContin over its central role in the deadly opioid crisis are negotiating a $10 billion to $12 billion settlement (Source: ABC News: Health)
Source: ABC News: Health - August 28, 2019 Category: Consumer Health News Tags: Health Source Type: news

Purdue Pharma in Discussion on $10 Bln-$12 Bln Offer to Settle Opioid Lawsuits - Sources Purdue Pharma in Discussion on $10 Bln-$12 Bln Offer to Settle Opioid Lawsuits - Sources
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 28, 2019 Category: Consumer Health News Tags: Public Health & Prevention News Source Type: news

OxyContin maker, governments in talks to settle lawsuits
States and local governments are in talks to settle lawsuits with the maker of the prescription painkiller OxyContin that is facing billions of dollars in potential liability for its role in the nation's opioid crisis (Source: ABC News: Health)
Source: ABC News: Health - August 28, 2019 Category: Consumer Health News Tags: Health Source Type: news

OxyContin Maker, Government Attorneys in Settlement Talks
FILE - This Feb. 19, 2013 file photo shows OxyContin pills arranged for a photo at a pharmacy in Montpelier, Vt. State attorneys general and lawyers representing local governments said Tuesday, Aug. 27, 2019, they are in active negotiations with Purdue Pharma, maker of the prescription painkiller OxyContin, as they attempt to reach a landmark settlement over the nation's opioid crisis. (AP Photo/Toby Talbot, File)   COLUMBUS, Ohio (AP) — State attorneys general and lawyers representing local governments said Tuesday they are in active settlement talks with Purdue Pharma, the maker of the prescription painkiller ...
Source: JEMS: Journal of Emergency Medical Services News - August 28, 2019 Category: Emergency Medicine Tags: News AP News Tag Source Type: news

Purdue Pharma offering billions to settle opioid crisis lawsuits
CBS News has learned Purdue Pharma, the maker of oxycontin is offering to pay billions of dollars to settle thousands of lawsuits stemming from the opioid crisis. Newly obtained video also shows the former head of Purdue Pharma defending the marketing of oxycontin. Anna Werner reports. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 28, 2019 Category: Consumer Health News Source Type: news

Purdue Pharma offers opioid settlement
CBS News has learned Purdue Pharma, the maker of OxyContin, has offered $5-6 billion to settle thousands of claims. It is unclear how much Purdue's owners, the Sackler family, would have to pay. (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - August 28, 2019 Category: Consumer Health News Source Type: news

OxyContin maker, government attorneys in settlement talks
State attorneys general and lawyers representing local governments say they are in active settlement negotiations amid a report that OxyContin maker Purdue Pharma has offered to settle for $10 billion to $12 billion (Source: ABC News: Health)
Source: ABC News: Health - August 28, 2019 Category: Consumer Health News Tags: Health Source Type: news

Purdue Pharma in discussion on $10 billion-$12 billion offer to settle opioid lawsuits: sources
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. (Source: Reuters: Health)
Source: Reuters: Health - August 28, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Johnson & Johnson ’s Brand Falters Over Its Role in the Opioid Crisis
An Oklahoma court case highlights the health care giant ’s role in the epidemic as a leading supplier of opioid ingredients. (Source: NYT)
Source: NYT - August 28, 2019 Category: American Health Authors: Katie Thomas and Tiffany Hsu Tags: Pain-Relieving Drugs Opioids and Opiates Johnson & Purdue Pharma Decisions and Verdicts OxyContin (Drug) Poppies Oklahoma Balkman, Thad Tasmania (Australia) Drugs (Pharmaceuticals) Advertising and Marketing Drug Abuse and Traffic Source Type: news

Sacklers Would Give Up Ownership of Purdue Pharma Under Settlement Proposal
The company is in discussions to resolve thousands of lawsuits. Participants in the talks value the plan at between $10 billion and $12 billion. (Source: NYT Health)
Source: NYT Health - August 28, 2019 Category: Consumer Health News Authors: Jan Hoffman Tags: Suits and Litigation (Civil) Pain-Relieving Drugs Opioids and Opiates Drugs (Pharmaceuticals) Drug Abuse and Traffic Bankruptcies OxyContin (Drug) Purdue Pharma Sackler Family your-feed-healthcare Source Type: news

Johnson & Johnson Was Ordered to Pay $572 Million for Its Role in the Opioid Crisis. With Similar Lawsuits Across the Country, That Could Be Just the Beginning
An Oklahoma judge ordered Johnson & Johnson to pay $572 million for its role in the opioid crisis in a historic ruling on Monday, marking the first time an opioid manufacturer has been deemed responsible in court and made to pay damages. It could have implications for the slew of lawsuits filed against opioid manufacturers and distributors throughout the country. A much bigger federal case before an Ohio judge involves at least 1,600 consolidated lawsuits from cities and counties from across the country, including hard-hit regions like Portsmouth, Ohio and Huntington, W.Va. The nationwide suit was filed in Ohio because...
Source: TIME: Health - August 28, 2019 Category: Consumer Health News Authors: Sanya Mansoor Tags: Uncategorized legal onetime opioids Source Type: news

Purdue Pharma in talks over multibillion-dollar deal to settle more than 2,000 opioid lawsuits
The company would declare bankruptcy, and its owners, the Sackler family, would lose control of the firm that makes OxyContin. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - August 28, 2019 Category: Consumer Health News Authors: Lenny Bernstein Source Type: news

Purdue and Sacklers offer to settle opioid suits for up to $12bn
The states, cities and counties which are pursuing the OxyContin maker because of large bills for cleaning up the opioid crisis are deciding whether to accept the offer by Friday, the people said. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 27, 2019 Category: Biotechnology Authors: Hannah Kuchler in New York Source Type: news

Purdue and Sacklers offer to settle opioid suits for up to $12bn
The states, cities and counties which are pursuing the OxyContin maker because of large bills for cleaning up the opioid crisis are deciding whether to accept the offer by Friday, the people said. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - August 27, 2019 Category: Pharmaceuticals Authors: Hannah Kuchler in New York Source Type: news

OxyContin maker Purdue Pharma seeking to settle 2,000 lawsuits for up to $12B
OxyContin maker Purdue Pharma and its owners, the Sackler family, are in discussion to settle more than 2,000 opioid lawsuits against the company for $10 billion to $12 billion US, two people familiar with the matter said on Tuesday. (Source: CBC | Health)
Source: CBC | Health - August 27, 2019 Category: Consumer Health News Tags: News/Business Source Type: news

OxyContin Maker Offers Up to & #36;12 Billion to Settle Opioid Claims
TUESDAY, Aug. 27, 2019 -- Purdue Pharma, the drug giant many have blamed for the ongoing U.S. opioid abuse crisis, has offered $10 billion to $12 billion to settle more than 2,000 lawsuits lodged against it, NBC News is reporting. The news comes a... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 27, 2019 Category: Pharmaceuticals Source Type: news

OxyContin Maker Purdue Offering Up to $12 Billion to Settle Opioid Claims
TUESDAY, Aug. 27, 2019 -- Purdue Pharma, the drug giant many have blamed for the ongoing U.S. opioid abuse crisis, has offered $10 billion to $12 billion to settle more than 2,000 lawsuits lodged against it, NBC News is reporting. The news comes a... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 27, 2019 Category: General Medicine Source Type: news

Why Was Johnson & Johnson the Only Opioid Maker on Trial in Oklahoma?
Other states are suing a range of drug makers, distributors and retailers. Here are three reasons Johnson& Johnson was the only company on trial in Oklahoma. (Source: NYT Health)
Source: NYT Health - August 27, 2019 Category: Consumer Health News Authors: Jan Hoffman Tags: Johnson & Opioids and Opiates Suits and Litigation (Civil) Drugs (Pharmaceuticals) Oklahoma OxyContin (Drug) your-feed-science Source Type: news

Individual short-acting opioids and the risk of opioid-related adverse events in adolescents - Chung CP, Callahan ST, Cooper WO, Dupont WD, Murray KT, Franklin AD, Hall K, Dudley JA, Stein CM, Ray WA.
PURPOSE: Hydrocodone, codeine, oxycodone, and tramadol are frequently prescribed to adolescents for moderate pain related to minor trauma or dental, surgical, or medical procedures. Pharmacokinetic and pharmacodynamic differences between these opioids coul... (Source: SafetyLit)
Source: SafetyLit - August 19, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

A Nun, a Doctor and a Lawyer — and Deep Regret Over the Nation’s Handling of Opioids
In an Appalachian town, an unlikely group of activists recognized the early stages of the deadly drug epidemic, and fought in vain to stem its rise. (Source: NYT Health)
Source: NYT Health - August 19, 2019 Category: Consumer Health News Authors: Barry Meier Tags: your-feed-science Opioids and Opiates Pain-Relieving Drugs Drug Abuse and Traffic Drugs (Pharmaceuticals) Nuns OxyContin (Drug) Purdue Pharma Virginia Pennington Gap, Va. Sister Beth Davies Dr. Art Van Zee Sue Ella Kobak Source Type: news

No Pre-Reading, No Rehearsing: How ‘The Weekly’ Kept Its Recreation of Historic Opioid Testimony Authentic
The Times TV show ’s producer/director shares the challenges and rewards of bringing to life witness testimony against Purdue Pharma in a way that stayed true to our journalistic principles. (Source: NYT)
Source: NYT - August 19, 2019 Category: American Health Authors: John Pappas Tags: Opioids and Opiates OxyContin (Drug) Purdue Pharma The Weekly (TV Program) Source Type: news

A Secret Opioid Memo That Could Have Slowed an Epidemic
A new TV Show from The New York Times on FX and Hulu. (Source: NYT Health)
Source: NYT Health - August 17, 2019 Category: Consumer Health News Tags: OxyContin (Drug) Sackler Family Purdue Pharma Justice Department Sackler, Richard (1945- ) Drug Abuse and Traffic The Weekly (TV Program) Hulu.com Source Type: news

New York Subpoenas Banks and Financial Advisers for Sackler Records
The state claims that the Purdue Pharma owners transferred billions of dollars from the company and hid them in offshore partnerships and other entities. (Source: NYT Health)
Source: NYT Health - August 15, 2019 Category: Consumer Health News Authors: Roni Caryn Rabin Tags: Banking and Financial Institutions Subpoenas Pain-Relieving Drugs Suits and Litigation (Civil) Opioids and Opiates OxyContin (Drug) Attorneys General James, Letitia Sackler Family New York State Purdue Pharma Source Type: news

Purdue Pharma sought to divert online readers from critical L.A. Times series on opioid crisis, records show
Purdue Pharma discussed diverting online readers away from L.A. Times stories about its marketing of OxyContin and the opiois crisis, court records show. (Source: L.A. Times - Health)
Source: L.A. Times - Health - August 15, 2019 Category: Consumer Health News Authors: Kim Christensen Source Type: news

Fentanyl deaths surged 150% last year in San Francisco last year, report reveals
Potent fentanyl has made its way to San Francisco, where 89 people fatally overdosed on the drug - often passed of for OxyContin - in 2018, new data from the city's health department reveals. (Source: the Mail online | Health)
Source: the Mail online | Health - August 12, 2019 Category: Consumer Health News Source Type: news

Indictment: Counterfeit Oxycodone Pills Contained Fentanyl Instead
Anthony Stokes, Deerfield MA, distributing counterfeit, (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - August 8, 2019 Category: Medical Law Authors: DOJ Source Type: news

China restricts opioid in tighter painkiller controls
China has imposed new restrictions on the opioid oxycodone, its drug regulator said, as the country tightens control of its painkillers industry in the battle against drug addiction. (Source: Reuters: Health)
Source: Reuters: Health - August 7, 2019 Category: Consumer Health News Tags: healthNews Source Type: news

Study: Opioid recovery requires more treatment than alcohol recovery
People addicted to drugs like oxycodone, hydrocodone and other opioids have a harder time kicking the habit than those addicted to alcohol, according to a new study. (Source: Health News - UPI.com)
Source: Health News - UPI.com - August 5, 2019 Category: Consumer Health News Source Type: news

Cranston Man Sentenced for Defrauding Social Security, Trafficking Oxycodone
Raymond Walker, attempt to possess with intent to distribute oxycodone, drug trafficking, inert pills (Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - August 2, 2019 Category: Medical Law Authors: DOJ Source Type: news

‘They Need to See the Families.’ Loved Ones of Overdose Victims Rally at Purdue Pharma Hearing
(BOSTON) — Parents who lost children to fatal overdoses and other addiction recovery activists are rallying outside a Boston courthouse Friday as a judge hears arguments in Massachusetts’ lawsuit against Purdue Pharma over its role in the national drug epidemic. About 100 protesters gathered in front of Suffolk County Superior Court before the start of the hearing, placing poster boards filled with photos of hundreds of overdose victims on the courthouse steps. One bore the words “Always loved, never forgotten.” Another: “We march for those who can’t.” A full-size skeleton covered ...
Source: TIME: Health - August 2, 2019 Category: Consumer Health News Authors: PHILIP MARCELO / AP Tags: Uncategorized Courts Massachusetts onetime Source Type: news

Arizona asks for US Supreme Court involvement in opioid case
Arizona's attorney general is asking the U.S. Supreme Court to force the Sackler family, which owns OxyContin-maker Purdue Pharma, to return billions of dollars they took out of the company (Source: ABC News: Health)
Source: ABC News: Health - August 1, 2019 Category: Consumer Health News Tags: Health Source Type: news

McKinsey Advised Johnson & Johnson on Increasing Opioid Sales
In a trial in Oklahoma, records showed the firm was consulted about sales at a time when abuse of pain medicine was widespread. Cases in two other states also shed light on its role. (Source: NYT Health)
Source: NYT Health - July 26, 2019 Category: Consumer Health News Authors: Walt Bogdanich Tags: Opioids and Opiates Drugs (Pharmaceuticals) Fentanyl Duragesic (Drug) OxyContin (Drug) Advertising and Marketing McKinsey & Johnson Janssen Pharmaceutica Purdue Pharma Teva Pharmaceutical Industries Ltd Balkman, Thad Oklahoma N Source Type: news

Revamped OxyContin was supposed to reduce abuse, but has it?
Data on harder-to-abuse OxyContin remains under wraps, raising questions about reformulation's effectiveness amid drug epidemic (Source: ABC News: Health)
Source: ABC News: Health - July 22, 2019 Category: Consumer Health News Tags: Health Source Type: news

They knew: Recently unsealed court documents reveal that makers of OxyContin purposely misled doctors and consumers about the strength of the drug
(Natural News) The opioid epidemic has been costly, there’s little doubt about that. With 47,600 deaths from opioid overdose in 2017 alone, the wave of death shows no signs of slowing down. And all the while, Big Pharma has been cashing out. Purdue Pharma, owned by the Sackler family and producer of the most infamous... (Source: NaturalNews.com)
Source: NaturalNews.com - July 18, 2019 Category: Consumer Health News Source Type: news

Data show "tsunami" of opioids across U.S. as death toll rose
Pharmaceutical firms shipped 76 billion oxycodone and other pills to drugstores as opioid epidemic was worsening (Source: Health News: CBSNews.com)
Source: Health News: CBSNews.com - July 17, 2019 Category: Consumer Health News Source Type: news

October 27, 2017: Central Kentucky Pharmacist Sentenced for Conspiracy to Distribute Oxycodone and Money Laundering
(Source: Office of Criminal Investigations (OCI) Press Releases)
Source: Office of Criminal Investigations (OCI) Press Releases - July 9, 2019 Category: Medical Law Authors: FDA Source Type: news

Survey Reveals Gaps in Opioid Rx Patterns of Orthopedic Surgeons
MONDAY, July 8, 2019 -- The vast majority of orthopedic surgeons recommend prescribing a nine-day supply of around-the-clock oxycodone doses following commonly performed orthopedic surgeries, according to a study published in the May/June issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - July 8, 2019 Category: Pharmaceuticals Source Type: news

UN Health Agency to Remove Controversial Opioid Guidelines
By CLAIRE GALOFARO Associated Press The World Health Organization notified U.S. lawmakers last Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the potent painkiller OxyContin. The lawmakers' report claimed the guidelines, crafted in part by organizations with financial ties to the company, downplay the risk of opioids despite...
Source: JEMS Patient Care - June 25, 2019 Category: Emergency Medicine Authors: Associated Press Tags: News Patient Care AP News Tag Source Type: news

UN Health Agency to Remove Controversial Opioid Guidelines
By CLAIRE GALOFARO Associated Press The World Health Organization notified U.S. lawmakers last Wednesday that it will discontinue two publications on prescribing opioid painkillers in response to allegations that the pharmaceutical industry influenced the reports. The pledge to remove the guidelines comes a month after U.S. Reps. Katherine Clark and Hal Rogers accused the WHO of being influenced by Purdue Pharma, the American manufacturer of the potent painkiller OxyContin. The lawmakers' report claimed the guidelines, crafted in part by organizations with financial ties to the company, downplay the risk of opioids despite...
Source: JEMS: Journal of Emergency Medical Services News - June 25, 2019 Category: Emergency Medicine Authors: Associated Press Tags: News Patient Care AP News Tag Source Type: news

Expert witness: Johnson & Johnson's role in opioid crisis may be 'worse' than Purdue's
One of the nation's top experts on opioid addiction said Tuesday that Johnson& Johnson's role in the current epidemic may be even "worse" than that of Purdue Pharma, the maker of OxyContin. (Source: CNN.com - Health)
Source: CNN.com - Health - June 11, 2019 Category: Consumer Health News Source Type: news